+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cardiac Ablation Market (2021-2026) by Product, Application, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon


  • 188 Pages
  • June 2021
  • Region: Global
  • Infogence Global Research
  • ID: 5410396

The Global Cardiac Ablation Market is estimated to be USD 2.43 Bn in 2021 and is expected to reach USD 4.26 Bn by 2026, growing at a CAGR of 11.9%.

Market Dynamics

The major driving factor of the global cardiac ablation market is, the rising healthcare awareness, technological advancements in ablation devices and arrhythmia diagnostic devices, and the growing demand for non-invasive procedures. Furthermost, the increasing case of cardiac arrhythmia is expected to drive the demand of the cardiac ablation market. For instance, according to the CDC, more than 750,000 hospitalizations occur each year because of atrial fibrillation. This also leads to nearly 130,000 deaths each year. Thus, the increasing number of cardiac arrhythmia cases is driving the market. In addition, the rising adoption of unhealthy lifestyles such as intake of excessive alcohol and smoking has increased the number of cardiovascular disease patients leading to growth opportunities for the global cardiac ablation market. However, strict regulations and risks involved with cardiac ablation procedures may affect the market growth. Also, the risk of complications related to the procedure such as damage to blood vessels, damage to heart valves, infection, and other such complications have restrained the growth of the market.

Market Segmentation

The Global Cardiac Ablation Market is segmented further based on Product, Application, and Geography.

By Product, the market is classified into Radiofrequency (RF) Ablators, Electrical Ablators, Cryoablation Devices, Ultrasound Ablators, and Microwave Ablators. Amongst all, Radiofrequency (RF) Ablators segment is estimated to hold the highest market share during the forecast period.

By Application, the market is classified as Cardiac Rhythm Management, Open Surgery, and Others. Amongst all, the Cardiac Rhythm Management segment is estimated to hold the highest market share during the forecast period.

By Geography, North America is projected to lead the market.

Recent Developments

1. Boston Scientific acquired the remaining 73% shares of Farapulse for $295m. With this acquisition, the company will support its current electrophysiology portfolio by adding the FARAPULSE Pulsed Field Ablation (PFA) System. - 24th June 2021
2. Olympus launches EVIS X1, its most advanced endoscopy system to date- 23rd April 2020

Company Profiles

Some of the companies covered in this report are Abbott Laboratories, Acutus Medical, Advanced Cardiac Therapeutics, Inc, Angio Dynamics, Inc, AtriCure, Inc, Baylis Medical, etc.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Cardiac Ablation Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst’s Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Cardiac Ablation Market

What is the estimated value of the Global Cardiac Ablation Market?

The Global Cardiac Ablation Market was estimated to be valued at $2430 Million in 2021.

What is the growth rate of the Global Cardiac Ablation Market?

The growth rate of the Global Cardiac Ablation Market is 11.9%, with an estimated value of $4260 Million by 2026.

What is the forecasted size of the Global Cardiac Ablation Market?

The Global Cardiac Ablation Market is estimated to be worth $4260 Million by 2026.

Who are the key companies in the Global Cardiac Ablation Market?

Key companies in the Global Cardiac Ablation Market include Abbott Laboratories, Acutus Medical, Advanced Cardiac Therapeutics, AngioDynamics, AtriCure, Baylis Medical, Biosense Webster, Biotronik and CONMED.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook
4 Market Influencers
4.1 Drivers
4.1.1 The Increasing Occurrences of Cardiac Arrhythmia
4.1.2 Growing Awareness for The Need for Early Diagnosis of Cardiovascular Diseases
4.2 Restraints
4.2.1 Strict Government Regulations and Policies
4.3 Opportunities
4.3.1 Increasing Funding in Research and Development Activities
4.3.2 Technological Advancements in Cardiac Ablation Devices
4.4 Challenges
4.4.1 The High-Level Risk Associated with Cardiac Ablation Procedures
4.5 Trends
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Cardiac Ablation Market, By Product
6.1 Introduction
6.2 Radiofrequency (RF) Ablators
6.2.1 Temperature-Controlled Radiofrequency Ablators
6.2.2 Fluid-Cooled Radiofrequency Ablators
6.2.3 Robotic Catheter Manipulation Systems
6.3 Electrical Ablators
6.3.1 Argon Plasma/Beam Coagulators
6.3.2 Irreversible Electroporation Ablators
6.4 Cryoablation Devices
6.4.1 Tissue Contact Probes
6.4.2 Tissue Spray Probes
6.5 Ultrasound Ablators
6.5.1 High-Intensity Focused Ultrasound Ablators
6.5.2 Magnetic Resonance Guided Focused Ultrasound Ablators
6.5.3 Ultrasound Ablation Systems
6.6 Microwave Ablators
6.6.1 Microwave Thermotherapy Devices
7 Global Cardiac Ablation Market, By Application
7.1 Introduction
7.2 Cardiac Rhythm Management
7.2.1 Cardiac Arrhythmia
7.2.2 Atrial Fibrillation and Flutter
7.2.3 Tachycardia
7.3 Open Surgery
7.4 Others
8 Global Cardiac Ablation Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 South America
8.3.1 Brazil
8.3.2 Argentina
8.3.3 Chile
8.3.4 Colombia
8.4 Europe
8.4.1 UK
8.4.2 France
8.4.3 Germany
8.4.4 Italy
8.4.5 Spain
8.4.6 Netherlands
8.4.7 Sweden
8.4.8 Russia
8.4.9 Rest of Europe
8.5 Asia-Pacific
8.5.1 China
8.5.2 Japan
8.5.3 India
8.5.4 Indonesia
8.5.5 Malaysia
8.5.6 South Korea
8.5.7 Australia
8.5.8 Sri Lanka
8.5.9 Thailand
8.5.10 Rest of APAC
8.6 Middle-East and Africa
8.6.1 Qatar
8.6.2 Saudi Arabia
8.6.3 South Africa
8.6.4 United Arab Emirates
9 Competitive Landscape
9.1 Competitive Quadrant
9.2 Market Share Analysis
9.3 Strategic Initiatives
9.3.1 M&A and Investments
9.3.2 Partnerships and Collaborations
9.3.3 Product Developments and Improvements
10 Company Profiles
10.1 Abbott Laboratories
10.2 Acutus Medical
10.3 Advanced Cardiac Therapeutics
10.4 AngioDynamics
10.5 AtriCure
10.6 Baylis Medical
10.7 Biosense Webster
10.8 Biotronik
10.9 Boston Scientific Corporation
10.10 CONMED
10.11 EPIX Therapeutics
10.12 Estech
10.13 Hansen Medical
10.14 Johnson and Johnson
10.15 Medtronic
10.16 Mount Sinai Health System
10.17 Olympus
10.18 RF Medical
10.19 Shanghai MicroPort Medical
10.20 Terumo Corporation
11 Appendix
11.1 Questionnaire

Companies Mentioned

  • Abbott Laboratories
  • Acutus Medical
  • Advanced Cardiac Therapeutics
  • AngioDynamics
  • AtriCure
  • Baylis Medical
  • Biosense Webster
  • Biotronik
  • Boston Scientific Corporation
  • EPIX Therapeutics
  • Estech
  • Hansen Medical
  • Johnson and Johnson
  • Medtronic
  • Mount Sinai Health System
  • Olympus
  • RF Medical
  • Shanghai MicroPort Medical
  • Terumo Corporation